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Two recent studies have demonstrated the presence of biologically significant amounts of cyanide within the airways of cystic fibrosis (CF)
patients infected with Pseudomonas aeruginosa. Whilst environmental strains of P. aeruginosa are known to synthesise cyanide, there has been a
relative lack of investigation into bacterial cyanogenesis from a medical viewpoint, despite the role P. aeruginosa plays in many serious infection
settings and especially in CF lung disease. This review discusses the implications of cyanogenesis in the CF airway in terms of bacterial ecology,
host immune response, progression of lung disease and potential treatment options.
© 2010 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.Keywords: Cystic fibrosis; Pseudomonas; Cyanogenesis; Toxicity; LungContents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
1.1. Biosynthesis and regulation of cyanide production by P. aeruginosa (Fig. 1) . . . . . . . . . . . . . . . . . . . . . . . . . 159
1.2. Magnitude of cyanide production by P. aeruginosa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
1.3. P. aeruginosa protects itself against cyanide toxicity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
1.4. Cyanogenesis may contribute to dominance and persistence of P. aeruginosa in the CF lung . . . . . . . . . . . . . . . . 161
1.5. Cyanide toxicity to host cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
1.6. Detoxification of cyanide by host cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
1.7. Cyanide production and the host innate immune response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
1.8. Potential effects of cyanide on neutrophil function in CF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
2. Targeting cyanide therapeutically . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
2.1. The use of cyanide antidotes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 162
2.2. Manipulating the CF micro-environment; therapeutic potential of supplementary oxygen . . . . . . . . . . . . . . . . . . 162
2.3. Cyanide as a potential biomarker for Pseudomonas infection status . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
3. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163⁎ Corresponding author. University of Tasmania Medical School, Collins
Street, Hobart 7001, Tasmania, Australia. Tel.: +61 3 6222 7043; fax: +61 3
62226 4894.
E-mail address: d.e.c.reid@utas.edu.au (D.W. Reid).
1569-1993/$ - see front matter © 2010 Published by Elsevier B.V. on behalf of Eu
doi:10.1016/j.jcf.2009.12.0031. Introduction
Cystic fibrosis is the most common lethal genetic disorder in
humans, affecting 70,000 individuals worldwide. The clinical
spectrum of CF disease is multifaceted, however the main factor
associated with morbidity and mortality is chronic respiratoryropean Cystic Fibrosis Society.
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tissue destruction [1]. Early lung disease is characterised by
intermittent infection with a variety of respiratory pathogens
and airway inflammation. Pulmonary infection with P.
aeruginosa, a ubiquitous Gram-negative biofilm forming
bacterium can be detected in a substantial proportion of
young infants with CF using bronchoscopic sampling techni-
ques [2,3]. Despite a robust local innate immune response and
aggressive antibiotic therapy, P. aeruginosa persists in CF
leading to a progressive decline in lung function and ultimately,
respiratory failure. The factors underlying the dominance and
persistence of P. aeruginosa in the CF lung are uncertain,
although the adoption of a biofilm-dwelling phenotype is
undoubtedly an important contributor that serves to increase
antibiotic resistance and the ability to evade the host immune
response [4].
Prior to the demonstration of high levels of cyanide in CF
sputum from P. aeruginosa infected patients [5,6], it had been
demonstrated that clinical strains of P. aeruginosa cultured ex
vivo produce cyanide and that this contributed to killing of
Drosophila melanogaster in a virulence model [7–9]. Hydro-
gen cyanide synthesis or cyanogenesis occurs in only a few
groups of bacteria, including the fluorescent pseudomonads
and cyanobacteria [10]. Cyanide production was first noted in
human infection several decades ago, but the role of
cyanogenesis in disease pathogenesis has not been pursued
further [11]. In this review, we discuss the potential
contribution of cyanogenesis to P. aeruginosa's success within
the CF lung.Fig. 1. Schematic representation of cyanide biosynthesis in mucoid P. aeruginosa
environment and a critical population density. The former is regulated in part by al
Although not the sole determinant, alginate also limits oxygen diffusion and the low
formation and dimerization of the ANR regulator [17], which then functions to activ
aeruginosa can grow under strictly anaerobic, denitrifying conditions, cyanide is no
acceptor [14]. In the other main regulatory pathway, when bacterial cell density reach
concentration and up-regulate transcription of hcnABC and thus cyanide production [7
the translational and post-transcriptional levels and RsmA— repressor of secondary m
level) [10,23].1.1. Biosynthesis and regulation of cyanide production by P.
aeruginosa (Fig. 1)
There remain many unknowns with respect to P. aeruginosa
cyanogenesis and several of the proposed biosynthetic process-
es have not been confirmed experimentally, but it is has been
established that glycine constitutes the amino acid substrate for
cyanide production [12,13]. Conversion of glycine to cyanide is
catalysed by cell membrane-associated hydrogen cyanide
synthase through a process of oxidative decarboxylation, during
which molecular oxygen functions as a terminal electron
acceptor [8,14,15]. However, HCN synthase is rapidly
inactivated by exposure to atmospheric oxygen concentrations
[14,16]. The cyanide synthase enzyme is encoded by the
hcnABC operon in P. aeruginosa [8]. The genetic control of this
operon and hence of cyanogenesis is complex and cyanide
biosynthesis occurs only under strict environmental condi-
tions [12]. The main factors influencing cyanogenesis are
decreased oxygen concentration and increased bacterial cell
density [17]. Maximal production of cyanide occurs between
34 °C and 37 °C under microaerophilic conditions [17]. There
are four main regulatory proteins involved in control of P.
aeruginosa cyanogenesis; the anaerobic regulator ANR, global
activator GacA, alginate regulator AlgR and RhlR [16,18].
Oxygen influences cyanide production via the anaerobic
regulator, which is a transcriptional regulator exquisitely
sensitive to environmental oxygen conditions [8,12,14]. The
ANR protein promotes cyanide synthase expression at low
oxygen levels, mediated by an oxygen responsive [4Fe–4S]2+. The two main control pathways are detection of an optimal oxygen-limited
gR, the gene that controls alginate production (mucoidy) in P. aeruginosa [7].
oxygen tensions experienced by bacterial cells stimulates [4Fe–4S]2+ cluster
ate transcription of the genes (hcnABC) controlling HCN synthase. Although P.
t produced anaerobically as the HCN synthase requires oxygen as an electron
es a critical threshold, Rhl autoinducers of the quorum sensing system increase in
,8,14,15,17,28,74]. GacA— global activator involved in hcnABC expression at
etabolites (mRNA binding protein that also functions at the post-transcriptional
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activate gene expression [8,14,15]. This regulatory mechanism
probably reflects an evolutionary survival mechanism whereby
cyanide's toxicity can be used to overcome competing
microbial populations that are depleting local oxygen levels
[14]. ANR also appears responsive to environmental iron
conditions and increased iron may promote cyanogenesis
through increased availability of Fe–S clusters and thus dimer
formation with resultant up-regulated hcnABC expression, but
these mechanisms require further investigation [10]. GacA
activity appears to be regulated by cell density and influences
cyanogenesis independently of ANR at both a transcriptional
and post-transcriptional level through modulatory effects on the
quorum sensor system (see below) and via a regulatory network
involving an RNA binding protein (RsmA) respectively, but the
exact mechanisms remain to be fully elucidated [10]. A
comprehensive overview of the control of P. aeruginosa
cyanogenesis is beyond the scope of this article, but there
have been recent excellent reviews on this subject and we direct
readers to these for further detailed information [8,15].
It has been postulated that the cyanide does not need to kill
competing microbes outright, as any inhibition of their
respiration will give P. aeruginosa a competitive advantage
[14]. Although the primary action of cyanide is via impairment
of cellular respiration, cyanide also binds to the iron,
molybdenum and copper cofactors of metalloproteins involved
in protection from oxidative stress, i.e. the superoxide
dismutases (SODs). These enzyme systems are primarily
expressed in aerobic bacteria, but many anaerobes also possess
them, which would be advantageous within the diseased CF
lung where the oxygen content varies considerably and bacteria
need to rapidly respond to changing micro-environmental
conditions. Cyanide production by P. aeruginosa in the CF
lung may therefore also harm anaerobic organisms, albeit to a
lesser extent than aerobic organisms [15,19,20]
The demonstration of cyanide accumulation in the CF lung has
added to the ongoing debate as towhethermicrobes in theCF lung
reside under aerobic, microaerophilic or anaerobic conditions, or
perhaps as is most likely, some combination of these scenarios.
The detection of sputum cyanide in reasonable concentrations
suggests that a substantial proportion of the P. aeruginosa
population in CF are living under microaerophilic conditions [6].
The quorum sensing (QS) system of P. aeruginosa is also
involved in regulation of expression of the hcnABC gene cluster
responsible for cyanogenesis, aswell as the expression ofmultiple
other virulence factors [7,21,22]. The QS system, particularly the
Rhl system (see below), may in turn be regulated by key genes
involved in biofilm formation such as algR, which controls the
synthesis of alginate, a major constituent of bacterial biofilms and
algRmay also partly regulate transcription of the hcnABC operon
[7]. These potential links between alginate synthesis and cyanide
production, probably explain the increased cyanide production
observed in mucoid strains of P. aeruginosa [7,22]. Pseudomo-
nas aeruginosa possesses three interdependent quorum-signal-
ling systems (Las, Rhl and PQS) [21]. Expression of the hcnABC
synthase operon is mainly controlled by the Rhl system. Once a
critical bacterial density is achieved, the Rhl QS system isactivated and autoinducer signalling molecules increase in
concentration and up-regulate genes, including hcnABC, explain-
ing why cyanide production peaks during transition from the late
exponential to stationary phase of bacterial replication [17]. There
are also suggestions that the global activator GacA (see above)
may increase cyanide synthesis at a transcriptional level via
effects on Rhl [23]. Intracellular glycine concentrations also rise
during the phase of rapid bacterial replication, but this by itself is
insufficient to activate cyanogenesis [14]. The trigger for
cyanogenesis is generation of local low oxygen concentrations
because of high bacterial consumption during exponential
growth. However, cyanide production then diminishes as
bacterial cells enter the stationary phase and oxygen levels once
again rise [12]. Interestingly, if anaerobic conditions are
deliberately imposed during stationary phase, cyanide synthase
activity will continue [12,14]. Representative of bacterial
numbers in the CF lung, CF sputum may contain N109 P.
aeruginosa per mL [24], numbers that exceed the critical cell
density threshold for cyanogenesis. Cyanogenesis is likely to be
encouraged by the presence of microaerophilic niches within the
CF lung and regions that are frankly anaerobic may permit
cyanogenesis, even during the stationary phase [14,25].1.2. Magnitude of cyanide production by P. aeruginosa
Pseudomonas aeruginosa cultures can produce levels up to
300–500 μM cyanide when grown under cyanogenic condi-
tions [8,17,26]. The amount of cyanide production achieved in
these culture models would be sufficient to inhibit aerobic
metabolism of competing organisms living in close proximity
due to the ease of diffusion by this small non-ionic molecule.
Microarray analyses of the transcriptome of a P. aeruginosa CF
isolate demonstrated a fourfold increase in expression of hcnB
when assessed directly in sputum samples compared to hcnB
expression in the same strain when grown in vitro [27],
suggesting robust cyanide production in vivo. The alginate
biosynthesis transcriptional regulator (AlgR) favours both
mucoidy and induction of hcnABC transcription during the
chronic phase of P. aeruginosa infection, which heralds
relentless clinical decline [7,28,29]. Alginate production itself
may promote cyanogenesis by providing a physical barrier that
limits oxygen diffusion [14,25].1.3. P. aeruginosa protects itself against cyanide toxicity
Cyanide inhibits aerobic respiration of prokaryote and
eukaryote cells by binding to the ferric (Fe3+) iron of the
cytochrome oxidase enzyme component of the respiratory
chain. Pseudomonas aeruginosa avoids cyanide toxicity
through a number of adaptations, including possession of an
additional terminal oxidase (cyanide insensitive oxidase, CIO),
which allows P. aeruginosa to tolerate concentrations of
cyanide in the millimolar concentration range under low
oxygen tensions [8,30–32]. Cyanide is also actively detoxified
by P. aeruginosa to thiocyanate via the enzyme rhodanese
(thiosulphate sulfurtransferase) [32,33].
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persistence of P. aeruginosa in the CF lung
As P. aeruginosa is a common soil and water inhabitant, the
majority of the research has focused on the biocontrol role of
cyanide in interspecies competition within these ecological
niches, but whether cyanogenesis is employed in a similar role
in the CF lung has not been considered.
Although P. aeruginosa becomes the dominant pathogen,
the CF lung supports a complex community of different
microbes. Interest has recently focused on the role of anaerobic
bacteria, as anaerobes are frequently present in numbers that
match those of P. aeruginosa within the CF lung [34]. Pseu-
domonas aeruginosa cyanogenesis may be partly driven by this
polymicrobial infection, as a response to both population
pressure and the low oxygen tensions encountered within
mucus-occluded airways in the CF lung. In vitro experiments
have demonstrated that cyanide production by P. aeruginosa
kills Staphylococcus aureus suggesting that cyanide's biocon-
trol function may also be active in the CF lung. Cyanide may
also indirectly kill bacteria within the CF lung by increasing
their susceptibility to conventional antibiotics via inhibition of
cytochrome oxidase-dependent drug efflux pumps [35], but
these potential interactions require further investigation in what
is obviously a very dynamic system.
1.5. Cyanide toxicity to host cells
Cyanide is toxic to mammalian cells, acting as a cellular
asphyxiant. The chemical structural similarity to oxygen [36],
explains cyanide's strong binding affinity to heme iron (Fe3+),
which is a key component of cytochrome-c oxidase (and other
flavoproteins). This enzyme is involved in the respiratory chain,
as part of aerobic respiration in mitochondria [37]. Cyanide is
primarily a mitochondrial poison, but it affects other biochem-
ical systems including activity of antioxidant enzymes [20].
Cyanide forces cells into anaerobic respiration causing a toxic
build up of lactic acid [38]. Organs, tissues and immune cells
that are metabolically active with a high oxygen demand are
therefore particularly vulnerable to cyanide.
Cyanide levels between 20 and 40 μM in the systemic
circulation result in cardiac toxicity and hypertension and levels
between 40 and 100 μM cause neurotoxicity, coma and
ultimately death [39]. Fatal blood cyanide concentrations are
variably reported to be N25 μM to N100 μM [40,41]. The levels
reported in CF sputa (up to 130 μM) are thus well within the
toxic range for cell aerobic respiration [5]. Levels may relate to
the clinical status of the patient, being higher in patients who are
acutely unwell and they are significantly lower following a
course of intravenous antibiotics [6]. Ryall et al. demonstrated
that sputum cyanide was negatively correlated with lung
function, perhaps indicating that more advanced lung disease
may facilitate cyanide production or alternatively, that cyanide
itself is contributing to disease severity, but prospective studies
are needed to adequately address this possibility. However,
regardless of the cause and effect question in this context, the
mean sputum cyanide concentrations reported in these tworecent studies (34 μM; Sanderson et al., and 72 μM; Ryall et al.,
respectively) are well within the range reported to be cytotoxic
[5,6].
Interestingly, cyanogenesis may not be limited to P.
aeruginosa in the CF lung as strains of the Burkholderia
cepacia complex (Bcc), which also infect the CF lung, have
recently been shown to synthesise cyanide ex vivo in
concentrations comparable to P. aeruginosa [42]. These
observations raise the potential for cyanide to contribute to
the development of necrotising pneumonia and the “cepacia
syndrome,” that is usually fatal in Bcc infected patients but this
requires further investigation [43].
1.6. Detoxification of cyanide by host cells
The body has the ability to detoxify cyanide through
conversion to thiocyanate, which is then excreted in urine.
This conversion requires thiosulfate and the related enzymes
rhodanese and mercaptopyruvate sulfurtransferase (MST),
which both occur widely in mammalian tissues, especially the
liver and kidney, including circulating red blood cells [44–47].
There are also minor non-rhodanese pathways for detoxification
of cyanide, for example complex formation with hydroxycoba-
lamin (a vitamin B12 precursor) [48]. The effects of cyanide are
exacerbated by poor nutrition by reducing the amount of
available thiosulphate, an important component in endogenous
cyanide detoxification [49]. Poor nutritional status is common
in CF and has been related to lung disease severity [50]. It is
worth speculating that CF-related malnutrition may impair the
body's endogenous detoxification of cyanide, contributing to
the long term deleterious effects of P. aeruginosa on disease
progression.
1.7. Cyanide production and the host innate immune response
Chronic P. aeruginosa colonisation of the CF lung is
characterised by a neutrophil dominated inflammatory re-
sponse. In normal lungs, neutrophils account for approximately
1% of all cells within the airway lumen, whereas in the CF
airway they account for up to 90% of the inflammatory cell
population and increased neutrophilic inflammation is observed
even in very young infants [51]. This florid neutrophilia is
ineffective at clearing infection and damages local tissues by the
production of excessive amounts of reactive oxygen species
(ROS) and proteases. It is generally agreed that the respiratory
failure associated with CF morbidity is primarily due to ongoing
and excessive activation of neutrophils within the airways. The
apparent failure of the innate immune system in CF has been the
subject of many studies and an excellent review of this subject
was recently published and we refer readers to this article for
further in-depth background information [52].
1.8. Potential effects of cyanide on neutrophil function in CF
The microbicidal function of neutrophils is a multi-step
process involving chemotaxis, phagocytosis, degranulation and
the respiratory burst (see Fig. 2). Review of the available
Fig. 2. Enzymatic reactions and products involved in the oxidative burst in
neutrophils. Phagocytosis is followed by the “respiratory oxidative burst” to
enable bacterial killing. This is a sequential process that involves the
nicotinamide adenine dinucleotide phosphate (NADPH) system oxidising
molecular oxygen to ROS including superoxide (O2
−) and production of
hydrogen peroxide (H202). These oxidants are further catalysed to hypochlorous
acid (HOCl) by myeloperoxidase (MPO). Reproduced by kind permission from
Hampton et al. [75,76].
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function provides conflicting reports. Classically, neutrophil
migration and phagocytosis have been considered to be
glycolysis-dependent, which is a non-mitochondrial energy
generating process and therefore theoretically relatively im-
mune to the effects of cyanide [53,54]. However, neutrophils
possess a mitochondrial network that is necessary for
maintenance of the integrity of the neutrophil cytoskeleton,
which is a prerequisite for normal migration and phagocytosis
[55–57]. Disruption of the neutrophil cytoskeleton as a
consequence of mitochondrial poisoning by cyanide has been
shown to cause morphological distortions, with cell flattening
and enlargement of nuclear structures [54]. The functional
consequences of these shape alterations have not been
adequately investigated, but a study by Fossati et al. has
demonstrated impaired chemotaxis in these abnormal neutro-
phils [54]. Review of the available literature on the effects of
cyanide on other components of neutrophil function provides
conflicting reports, with some studies demonstrating inhibitory
effects on the oxidative burst, or specific components that are
required for bacterial killing, i.e. chlorination of bacterial cell
membranes [58], whereas some investigators have demonstrat-
ed an enhanced oxidative burst [59,60] and others no
discernible effect. Whether stimulatory or inhibitory, the effects
of cyanide on the oxidative burst of neutrophils are probably
mediated via modulation of NADPH oxidase activity (see
Fig. 2). Cyanide may also inhibit the activity of neutrophil
catalase, which normally scavenges H2O2 to limit its toxicity,
thus allowing oxidative stress to continue unabated, which is acharacteristic of CF lung disease [61–63]. The results of studies
of cyanide effects on neutrophil phagocytosis are also
somewhat conflicting, although the majority suggest that there
is no significant inhibition [54,64]. The potentially important
effects of cyanide on neutrophil function in the CF lung need
further investigation, to determine whether cyanide may
contribute to impaired bacterial clearance and increased
production of damaging pro-oxidants.
2. Targeting cyanide therapeutically
2.1. The use of cyanide antidotes
The binding reaction between cyanide and cytochrome-c
oxidase can be reversed by administration of nitrites, sodium
thiosulphate and hydroxocobalamin and these compounds are
used as antidotes to systemic cyanide poisoning [65]. Nitrites
alter the redox state of iron in haemoglobin, reducing a small
proportion of ferrous (Fe2+) haemoglobin to methaemoglobin
(Fe3+ haemoglobin), which has a higher binding affinity to
cyanide than cytochrome oxidase. Cyanide bound to methae-
moglobin is non-toxic, but excessive methaemoglobin will
compromise oxygen carriage and this would be a limiting factor
to consideration of the use of nitrites in the long term [39].
Sodium thiosulphate acts as a sulphur donor for rhodanese
enzymes, catalysing the conversion of cyanide to thiocyanate,
which is then excreted in the urine. This is the body's natural
cyanide detoxification mechanism, but its use as a substrate is
limited by the availability of rhodanese. Although, sodium
thiosulphate acts more slowly than alternative antidotes, there
are no serious side effects associated with short-term use at the
recommended dose [37] and so it may well present a viable
therapeutic approach to minimise cyanide toxicity in the CF
lung, although whether systemic administration would be
effective as an antidote in the lung would need assessment.
The vitamin B12 precursor, hydroxocobalamin chelates
cyanide to form the non-toxic cyanocobalamin, which is excreted
in the urine. Hydroxocobalamin (alone or in combination with
sodium thiosulfate) has been successfully used in patients
receiving prolonged intravenous sodium nitroprusside to prevent
cyanide toxicity and hydroxocobalamin treatment improves
survival following cyanide poisoning [48,66]. Cobinamide is a
precursor of hydroxocobalamin, which is effective as a cyanide
antidote at much lower doses [67]. Cobinamide is attractive in CF
as it can be delivered by inhalation, which has previously led to
discussion of its use as a possible cyanide antidote in the CF lung
[67]. However, to date there are no data available on the use of any
of these antidotes in CF patients.
2.2. Manipulating the CF micro-environment; therapeutic
potential of supplementary oxygen
An alternative strategy is to consider whether cyanide
production by P. aeruginosa can be reduced within the CF
lung. Hyperbaric oxygen therapy (HBOT) may be a potential
means by which the CF lung micro-environment could be altered
to switch off P. aeruginosa cyanogenesis. The benefits of HBOT
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explained by effects on biofilm-dwelling bacteria, although there
are very few data on this subject [68]. The main consideration in
CF would be whether HBOT would have adverse effects on lung
mechanics and such therapy would only be suitable for use in
short pulses and reserved for acutely unwell patients [69].
2.3. Cyanide as a potential biomarker for Pseudomonas
infection status
The use of selected ion flow tube mass spectrometry (SIFT-
MS) has been studied as a non-invasive method for detecting
volatile compounds from cultured sputa or direct breath analysis
in a variety of airway diseases, including CF [70]. Measurement
of cyanide as a biomarker of Pseudomonas infection has been
undertaken in CF patient saliva and exhaled breath [71].
Cyanide detection as an indicator of P. aeruginosa infection
would be especially useful as a non-invasive marker in
paediatric patients and allow the effectiveness of eradication
therapy to be accurately assessed, as well as provide early
warning of impending exacerbation in both children and adults.
An alternative would be to assess the presence of stable cyanide
metabolites, such as thiocyanate in biological fluids. The
existence of methods for detecting thiocyanate levels in plasma
and urine lend rationale to this approach and thiocyanate has
recently been detected in the saliva of children with CF [72].
3. Conclusion
In summary, cyanide is an important metabolic product of P.
aeruginosa that has potential implications in terms of exacerbat-
ing lung damage, promoting disease progression and reducing the
effectiveness of the host response in CF. Further research is
needed, but confirming the disease-modifying role of cyanogen-
esis in CF lung disease may lead to new therapies to directly
reduce toxicity, as well as the development of biomarkers that
could be used to optimise therapy options. The recent successful
detection of cyanide and metabolites in biological samples from
P. aeruginosa infected individuals, including exhaled breath
condensates, opens the door to improved monitoring of targeted
anti-P. aeruginosa interventions and possibly screening for early
infection and impending exacerbation [71,73].
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